Reacta Healthcare Secures 12th Place in The Sunday Times 100 Tech 2026

Reacta Healthcare is proud to announce that we have ranked 12th in the Sunday Times 100 Tech 2026, a prestigious list celebrating the UK’s fastest-growing and most innovative technology companies. This recognition reflects both our commercial momentum and our commitment to transforming food allergy diagnosis for patients worldwide.

Over the past three years, Reacta has delivered 117.05% annual sales growth, demonstrating strong and sustained commercial progress. This growth has been fuelled by the scientific innovation and engineering excellence at the core of our work, and by a team dedicated to pushing the boundaries of what’s possible in food allergy diagnostics.
“This recognition for Reacta represents a significant step in the company’s evolution and embodies our employees’ commitment and belief in our vision.”

– Paul Abrahams, CEO

The Tech category places a spotlight on organisations whose success is driven by engineering, biotech, hardware-led platforms, and scientific invention. Being recognised in this space holds particular meaning for Reacta, reaffirming the impact of our mission and the strength of our technology.

This achievement would not be possible without the trust and collaboration of our colleagues, partners, and customers. Together, we are making meaningful progress toward improving the quality of life for food allergy patients globally.

We’re excited for the journey ahead as we continue scaling our impact, expanding internationally, and delivering innovative solutions that support clearer, safer, and more precise food allergy diagnosis.